Curation of Mini Mental State Examination (MMSE) Scores in the VA Million Veteran Program (MVP): Applications for Cognitive Aging Research
Lopez, F. V.; Gillis, M.; Lee, S.; Sakamoto, M. S.; Zhang, R.; VA Million Veteran Program, ; Sherva, R.; Logue, M.; Merritt, V. C.
Show abstract
Background: Electronic health record (EHR)-linked biorepositories provide opportunities to advance epidemiological research in Alzheimer's disease (AD) and related dementias. Objective: Evaluate the extraction, curation, and associative validity of Mini Mental State Examination (MMSE) scores from the VA EHR for participants in the VA Million Veteran Program (MVP). Methods: The sample (N = 49,555; 7.4% women) included a multiethnic cohort (European [68.3%], African [20.4%], Hispanic [9.0%]) with EHR-extracted MMSE scores; 30.7% were apolipoprotein E (APOE) {epsilon}4 carriers, and 25.8% had multiple scores. Linear regressions examined cross-sectional associations between {epsilon}4 dosage (0, 1, 2) and first and lowest MMSE scores. MMSE scores were also evaluated against MVP dementia diagnostic algorithms in participants aged [≥]65 years. Results: Among participants of European ancestry, there was a significant {epsilon}4 dose-response relationship (ps < .001) with MMSE scores. Homozygote carriers scored lower than heterozygote carriers (Mdiff: first = -0.5; lowest = -0.9), who scored lower than non-carriers (Mdiff: first = -0.4; lowest = -0.6). Among Veterans of African and Hispanic ancestry, no dose-response relationship was observed, although {epsilon}4 carriers had lower scores than non-carriers (ps [≤] .04). MMSE scores corresponded strongly with dementia case/control status across phenotypes: mild impairment on the MMSE was strongly associated with AD (odds ratio [OR] = 11.48), with more severe MMSE impairment showing stronger associations (moderate OR = 17.95; severe OR = 27.83). Conclusion: This study demonstrated MMSE scores can be systematically extracted and curated from the VA EHR. Findings offer a scalable framework for future studies on risk stratification, highlighting the potential for harnessing MVP to explore genetic and clinical factors contributing to cognitive and dementia outcomes in diverse samples.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Evaluation of a speech-based AI system for early detection of Alzheimer’s disease remotely via smartphones 95%
- Clinical Validation and Machine Learning Optimization of MyCog: A Self-Administered Cognitive Screener for Primary Care Settings 95%
- Persistence of Neuropsychiatric Symptoms and Dementia Prognostication: A Comparison of Three Operational Definitions of Mild Behavioral Impairment 95%
Similar papers in this journal
- Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study 95%
- Frequency of Variants in Mendelian Alzheimer’s Disease Genes within the Alzheimer’s Disease Sequencing Project (ADSP) 95%
- Quantitative longitudinal predictions of Alzheimer's disease by multi-modal predictive learning 94%
Similar papers in this journal
- Continuous Associations Between Remote Self-Administered Cognitive Measures and Imaging Biomarkers of Alzheimer’s Disease 96%
- Using Machine Learning and Electronic Health Record (EHR) Data for the Early Prediction of Alzheimer’s Disease and Related Dementias 94%
- Use of Lecanemab and Donanemab in the Canadian Healthcare System: Evidence, Challenges, and Areas for Future Research 94%
Similar papers in this journal
- Examining a Preclinical Alzheimer’s Cognitive Composite for Telehealth Administration, the tPACC, for Reliability between In-Person and Remote Cognitive Testing with Neuroimaging Biomarkers 97%
- Effect of Pathway-specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals 95%
- Inferring Alzheimer’s disease pathologic traits from clinical measures in living adults 95%